Delivery Order SPE2DB22D3011-SPE2DB24FP8QL
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vivitrol 380 mg vials and diluents, a medication used for the treatment of alcohol and opioid dependence. The contract has a ceiling value of $4,571.55 and a performance period through February 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vivitrol 380 mg vials and diluents, a medication used for the treatment of alcohol and opioid dependence. The contract is a firm-fixed price arrangement with a ceiling value of $1,135. The contract has a period of performance running through February 13, 2025. This award is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vivitrol 380 mg vials and diluents, a medication used for the treatment of opioid dependence and alcohol dependence. The contract is a firm fixed-price delivery order with a ceiling value of $1,001.17 and a period of performance through May 8, 2025. This contract is not a set-aside and was competitively awarded....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vivitrol 380 mg vials and diluents, a medication used for the treatment of alcohol and opioid dependence. The contract is a firm fixed-price delivery order with a ceiling value of $5,799.80 and a performance period through May 15, 2025. The contract was not set aside for any specific...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Vivitrol 380 mg vials and diluents. The contract has a ceiling value of $11,180.53 and a completion date of September 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vivitrol 380 mg vials and diluents, a medication used in the treatment of opioid dependence and alcohol dependence. The contract has a ceiling value of $1,828.96 and an ultimate completion date of May 5, 2023. This award is a firm fixed-price delivery order and was not set...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract has a ceiling value of $2,681.39 and an ultimate completion date of January 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vivitrol 380 mg vial-diluents, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has a ceiling value of $10,011.70 and is a firm fixed price, non-set-aside delivery order with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of alcohol and opioid dependence. The contract has a ceiling value of $1,001.17 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition. The contract is part...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vivitrol 380 mg vials and diluents, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has a firm fixed price, with a ceiling value of $6,007.02, and a period of performance through May 6, 2025. This contract is not designated as a...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP8QLDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vivitrol 380 mg vials and diluents, a medication used in the treatment of opioid dependence and alcohol dependence. The contract has a ceiling value of $5,820.20 and a period of performance through January 18, 2024. This award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 1/17/24 |